Biomarkers of Alzheimer disease in mild cognitive impairment: Experience in a memory clinic from Latin America R.F. Allegri; P. Chrem Mendez; M.J. Russo; G. Cohen; I. Calandri; J. Campos; F. Nahas; E. Surace; S. Vazquez; G. Sevlever;

Argentinian/Chilean validation of the Spanish-language version of Addenbrooke's Cognitive Examination III for diagnosing dementia D. Bruno; A. Slachevsky; N. Fiorentino; D.S. Rueda; G. Bruno; A.R. Tagle; L. Olavarria; P. Flores; P. Lillo; M. Roca; T. Torralva;

The CORCOBIA study: Cut-off points of Alzheimer¿s disease CSF biomarkers in a clinical cohort A. Puig-Pijoan; G. García-Escobar; A. Fernández-Lebrero; R.M. Manero-Borràs; G. Sánchez-Benavides; I. Navalpotro-Gómez; D. Cascales Lahoz; M. Suárez-Calvet; O. Grau-Rivera; A. Boltes Alandí; M.C. Pont-Sunyer; J. Ortiz-Gil; S. Carrillo-Molina; D. López-Villegas; M.T. Abellán-Vidal; M.I. Martínez-Casamitjana; J.J. Hernández-Sánchez; J. Peña-Casanova; J. Roquer; A. Padrós Fluvià; V. Puente-Périz;